AI-Powered Psychedelic Treatments: Special Status And Next-Gen Contests Winners

BenzingaJun 8, 2023 17:25 ET

Eli Lilly Releases Results On Latest Disease Modifying Therapeutic For Alzheimer's Disease, Highlighting Need For Cognetivity's CognICA Platform

BenzingaMay 9, 2023 09:31 ET

UK-Based Psychedelics Ancillary Business Wraps Up $3M Funding Round

Benzinga Real-time NewsOct 28, 2022 08:16 ET

Ketamine One Teams Up With Cognetivity Neurosciences To Study PTSD, Depression

Benzinga Real-time NewsDec 2, 2021 12:36 ET

Press Release: Cognetivity Neurosciences Announces Securities Issuances

Dow Jones NewswiresNov 5, 2021 14:30 ET

Press Release: Cognetivity Neurosciences Wins Health & Technology Awards and Announces Corporate Update

Dow Jones NewswiresOct 13, 2021 14:42 ET